Guided Therapeutics (GTHP) Dividends Paid - Common Growth (1y) (2024)
Guided Therapeutics (GTHP) Dividends Paid - Common Growth (1y) (2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Paid (Common) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.40 Bn | 176.11 Bn | 6.27 Bn | 7.02% |
| 2 | Stryker | 128.93 Bn | 126.05 Bn | 3.81 Bn | 5.31% |
| 3 | Medtronic | 108.35 Bn | 99.13 Bn | 6.41 Bn | 1.23% |
| 4 | Boston Scientific | 68.71 Bn | 67.25 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.35 Bn | 44.68 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.37 Bn | 27.25 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 28.04 Bn | 25.76 Bn | 1.98 Bn | 0.00% |
| 8 | Smith & Nephew | 26.90 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn | -11.30% |
| 10 | Guided Therapeutics | 20.78 Mn | 20.72 Mn | 458,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 0.00% |